美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA079162"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
43353-695-60 43353-695 HUMAN PRESCRIPTION DRUG Topiramate topiramate TABLET ORAL 20110720 N/A ANDA ANDA079162 Aphena Pharma Solutions - Tennessee, LLC TOPIRAMATE 25 mg/1 90 TABLET in 1 BOTTLE (43353-695-60)
43353-695-80 43353-695 HUMAN PRESCRIPTION DRUG Topiramate topiramate TABLET ORAL 20110712 N/A ANDA ANDA079162 Aphena Pharma Solutions - Tennessee, LLC TOPIRAMATE 25 mg/1 180 TABLET in 1 BOTTLE (43353-695-80)
43353-696-60 43353-696 HUMAN PRESCRIPTION DRUG Topiramate topiramate TABLET ORAL 20110712 N/A ANDA ANDA079162 Aphena Pharma Solutions - Tennessee, LLC TOPIRAMATE 100 mg/1 90 TABLET in 1 BOTTLE (43353-696-60)
43353-696-80 43353-696 HUMAN PRESCRIPTION DRUG Topiramate topiramate TABLET ORAL 20110810 N/A ANDA ANDA079162 Aphena Pharma Solutions - Tennessee, LLC TOPIRAMATE 100 mg/1 180 TABLET in 1 BOTTLE (43353-696-80)
43353-697-30 43353-697 HUMAN PRESCRIPTION DRUG Topiramate topiramate TABLET ORAL 20181112 N/A ANDA ANDA079162 Aphena Pharma Solutions - Tennessee, LLC TOPIRAMATE 200 mg/1 30 TABLET in 1 BOTTLE (43353-697-30)
43353-697-60 43353-697 HUMAN PRESCRIPTION DRUG Topiramate topiramate TABLET ORAL 20181112 N/A ANDA ANDA079162 Aphena Pharma Solutions - Tennessee, LLC TOPIRAMATE 200 mg/1 90 TABLET in 1 BOTTLE (43353-697-60)
76282-278-10 76282-278 HUMAN PRESCRIPTION DRUG Topiramate Topiramate TABLET ORAL 20200907 N/A ANDA ANDA079162 EXELAN PHARMACEUTICALS INC. TOPIRAMATE 25 mg/1 1000 TABLET in 1 BOTTLE (76282-278-10)
76282-278-60 76282-278 HUMAN PRESCRIPTION DRUG Topiramate Topiramate TABLET ORAL 20200907 N/A ANDA ANDA079162 EXELAN PHARMACEUTICALS INC. TOPIRAMATE 25 mg/1 60 TABLET in 1 BOTTLE (76282-278-60)
76282-279-10 76282-279 HUMAN PRESCRIPTION DRUG Topiramate Topiramate TABLET ORAL 20200907 N/A ANDA ANDA079162 EXELAN PHARMACEUTICALS INC. TOPIRAMATE 50 mg/1 1000 TABLET in 1 BOTTLE (76282-279-10)
76282-279-60 76282-279 HUMAN PRESCRIPTION DRUG Topiramate Topiramate TABLET ORAL 20200907 N/A ANDA ANDA079162 EXELAN PHARMACEUTICALS INC. TOPIRAMATE 50 mg/1 60 TABLET in 1 BOTTLE (76282-279-60)
76282-280-10 76282-280 HUMAN PRESCRIPTION DRUG Topiramate Topiramate TABLET ORAL 20200907 N/A ANDA ANDA079162 EXELAN PHARMACEUTICALS INC. TOPIRAMATE 100 mg/1 1000 TABLET in 1 BOTTLE (76282-280-10)
76282-280-60 76282-280 HUMAN PRESCRIPTION DRUG Topiramate Topiramate TABLET ORAL 20200907 N/A ANDA ANDA079162 EXELAN PHARMACEUTICALS INC. TOPIRAMATE 100 mg/1 60 TABLET in 1 BOTTLE (76282-280-60)
76282-281-10 76282-281 HUMAN PRESCRIPTION DRUG Topiramate Topiramate TABLET ORAL 20200907 N/A ANDA ANDA079162 EXELAN PHARMACEUTICALS INC. TOPIRAMATE 200 mg/1 1000 TABLET in 1 BOTTLE (76282-281-10)
76282-281-60 76282-281 HUMAN PRESCRIPTION DRUG Topiramate Topiramate TABLET ORAL 20200907 N/A ANDA ANDA079162 EXELAN PHARMACEUTICALS INC. TOPIRAMATE 200 mg/1 60 TABLET in 1 BOTTLE (76282-281-60)
69097-816-03 69097-816 HUMAN PRESCRIPTION DRUG Topiramate Topiramate TABLET ORAL 20160722 N/A ANDA ANDA079162 Cipla USA Inc. TOPIRAMATE 25 mg/1 60 TABLET in 1 BOTTLE (69097-816-03)
69097-816-12 69097-816 HUMAN PRESCRIPTION DRUG Topiramate Topiramate TABLET ORAL 20160722 N/A ANDA ANDA079162 Cipla USA Inc. TOPIRAMATE 25 mg/1 500 TABLET in 1 BOTTLE (69097-816-12)
69097-816-15 69097-816 HUMAN PRESCRIPTION DRUG Topiramate Topiramate TABLET ORAL 20160722 N/A ANDA ANDA079162 Cipla USA Inc. TOPIRAMATE 25 mg/1 1000 TABLET in 1 BOTTLE (69097-816-15)
69097-817-03 69097-817 HUMAN PRESCRIPTION DRUG Topiramate Topiramate TABLET ORAL 20160722 N/A ANDA ANDA079162 Cipla USA Inc. TOPIRAMATE 50 mg/1 60 TABLET in 1 BOTTLE (69097-817-03)
69097-817-12 69097-817 HUMAN PRESCRIPTION DRUG Topiramate Topiramate TABLET ORAL 20160722 N/A ANDA ANDA079162 Cipla USA Inc. TOPIRAMATE 50 mg/1 500 TABLET in 1 BOTTLE (69097-817-12)
69097-817-15 69097-817 HUMAN PRESCRIPTION DRUG Topiramate Topiramate TABLET ORAL 20160722 N/A ANDA ANDA079162 Cipla USA Inc. TOPIRAMATE 50 mg/1 1000 TABLET in 1 BOTTLE (69097-817-15)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase